Amarin reported $-5140000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
DBV Technologies DBVT:US USD -17287000 5.75M
Abbvie ABBV:US USD 3.95B 3.03B
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amarin AMRN:US USD -5140000 64.82M
AstraZeneca AZN:LN USD 1.64B 1.28B
Biocryst Pharmaceuticals BCRX:US USD -42520000 16.34M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Neurocrine Biosciences NBIX:US USD 68.5M 85.4M
Novartis NOVN:VX USD 1.57B 121M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M